Back to search

Article

SF3B4 Drives Alternative 5′ Splice Site Selection of HOXA11-AS to Promote Metabolic Reprogramming and Reduced Cisplatin Sensitivity in ESCC

2026-08-12

Abstract excerpt

<title>Abstract</title> <p>Reduced cisplatin sensitivity limits treatment responses in esophageal squamous cell carcinoma (ESCC), yet the isoform-level RNA-processing mechanisms that connect metabolic adaptation to treatment response remain poorly defined. Here, integrative analyses of public datasets and clinical cohorts identified splicing factor 3b subunit 4 (SF3B4) as an ESCC-upregulated splicing regulator an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21517aae-a294-503e-bcbf-e4354bbc6e71
DOI
10.21203/rs.3.rs-10663843/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SF3B4 Drives Alternative 5′ Splice Site Selection of HOXA11-AS to Promote Metabolic Reprogramming and Reduced Cisplatin Sensitivity in ESCCDOI 10.21203/rs.3.rs-10663843/v1
Select a neighboring publication to make it the new centre.